Vaccine hesitancy and coronavirus disease-19: Where do we stand?
BACKGROUND: Vaccine hesitancy is seen, globally, as a major factor that will determine future coronavirus disease-19 (COVID-19) spread and its effective management. This study aimed to identify COVID-19 vaccine perception, acceptance, confidence, hesitancy, and barriers among the general population....
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Journal of Education and Health Promotion |
| Subjects: | |
| Online Access: | http://www.jehp.net/article.asp?issn=2277-9531;year=2022;volume=11;issue=1;spage=59;epage=59;aulast=Khan |
| _version_ | 1818489421714948096 |
|---|---|
| author | Zaid Khan Syed Quibtiya Khursheed Shabir Ahmad Dar Naveed Nazir Shah Shuja Reagu Majid Alabdulla Inaamul Haq Aaliya Mohi Ud Din Azad Khurshid Ahmad Dar Syed Suraiya Farooq Zaid Ahmad Wani |
| author_facet | Zaid Khan Syed Quibtiya Khursheed Shabir Ahmad Dar Naveed Nazir Shah Shuja Reagu Majid Alabdulla Inaamul Haq Aaliya Mohi Ud Din Azad Khurshid Ahmad Dar Syed Suraiya Farooq Zaid Ahmad Wani |
| author_sort | Zaid Khan |
| collection | DOAJ |
| description | BACKGROUND: Vaccine hesitancy is seen, globally, as a major factor that will determine future coronavirus disease-19 (COVID-19) spread and its effective management. This study aimed to identify COVID-19 vaccine perception, acceptance, confidence, hesitancy, and barriers among the general population.
MATERIALS AND METHODS: This was an online survey which was developed and shared through social media platforms among the general population of Kashmir. The survey captured demographic data and used a validated hesitancy measurement tool. We analyzed the data using descriptive statistics and multivariable logistic regression using Stata 15 (Stata Corp. 2017. Stata Statistical Software: Release 15. College Station, TX, USA: Stata Corp LLC).
RESULTS: A total of 835 responses were received. Most participants were males, with females compromising of 19.5% participants. 65.1% of participants were in the age group of 30–50, whereas 19.2% were below 30 years of age. 52.70% of respondents were willing to take the vaccine when available, while 32.5% of respondents were unsure about their decision of inoculation. The most cited reason for willingness to get vaccinated was an understanding of the disease and vaccination. 41.70% felt that the vaccines developed against COVID-19 have not been fully tested; therefore, concerns around the safety and its longer-term side effects were the reasons cited. Public health messaging should be tailored to address these concerns.
CONCLUSIONS: Vaccine hesitancy is a global threat undermining the control of preventable infections. The government should take proactive steps to address the factors that may potentially impact the benefits expected from the introduction of a COVID-19 vaccine in the union territory. |
| first_indexed | 2024-12-10T17:03:45Z |
| format | Article |
| id | doaj.art-923e1afa02db45cea23222720efa5d18 |
| institution | Directory Open Access Journal |
| issn | 2277-9531 |
| language | English |
| last_indexed | 2024-12-10T17:03:45Z |
| publishDate | 2022-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Education and Health Promotion |
| spelling | doaj.art-923e1afa02db45cea23222720efa5d182022-12-22T01:40:30ZengWolters Kluwer Medknow PublicationsJournal of Education and Health Promotion2277-95312022-01-01111595910.4103/jehp.jehp_642_21Vaccine hesitancy and coronavirus disease-19: Where do we stand?Zaid KhanSyed Quibtiya KhursheedShabir Ahmad DarNaveed Nazir ShahShuja ReaguMajid AlabdullaInaamul HaqAaliya Mohi Ud Din AzadKhurshid Ahmad DarSyed Suraiya FarooqZaid Ahmad WaniBACKGROUND: Vaccine hesitancy is seen, globally, as a major factor that will determine future coronavirus disease-19 (COVID-19) spread and its effective management. This study aimed to identify COVID-19 vaccine perception, acceptance, confidence, hesitancy, and barriers among the general population. MATERIALS AND METHODS: This was an online survey which was developed and shared through social media platforms among the general population of Kashmir. The survey captured demographic data and used a validated hesitancy measurement tool. We analyzed the data using descriptive statistics and multivariable logistic regression using Stata 15 (Stata Corp. 2017. Stata Statistical Software: Release 15. College Station, TX, USA: Stata Corp LLC). RESULTS: A total of 835 responses were received. Most participants were males, with females compromising of 19.5% participants. 65.1% of participants were in the age group of 30–50, whereas 19.2% were below 30 years of age. 52.70% of respondents were willing to take the vaccine when available, while 32.5% of respondents were unsure about their decision of inoculation. The most cited reason for willingness to get vaccinated was an understanding of the disease and vaccination. 41.70% felt that the vaccines developed against COVID-19 have not been fully tested; therefore, concerns around the safety and its longer-term side effects were the reasons cited. Public health messaging should be tailored to address these concerns. CONCLUSIONS: Vaccine hesitancy is a global threat undermining the control of preventable infections. The government should take proactive steps to address the factors that may potentially impact the benefits expected from the introduction of a COVID-19 vaccine in the union territory.http://www.jehp.net/article.asp?issn=2277-9531;year=2022;volume=11;issue=1;spage=59;epage=59;aulast=Khancoronavirus disease-19coronavirus disease-19 vaccinemistrustparticipantsside effectsvaccine acceptancevaccine hesitancy |
| spellingShingle | Zaid Khan Syed Quibtiya Khursheed Shabir Ahmad Dar Naveed Nazir Shah Shuja Reagu Majid Alabdulla Inaamul Haq Aaliya Mohi Ud Din Azad Khurshid Ahmad Dar Syed Suraiya Farooq Zaid Ahmad Wani Vaccine hesitancy and coronavirus disease-19: Where do we stand? Journal of Education and Health Promotion coronavirus disease-19 coronavirus disease-19 vaccine mistrust participants side effects vaccine acceptance vaccine hesitancy |
| title | Vaccine hesitancy and coronavirus disease-19: Where do we stand? |
| title_full | Vaccine hesitancy and coronavirus disease-19: Where do we stand? |
| title_fullStr | Vaccine hesitancy and coronavirus disease-19: Where do we stand? |
| title_full_unstemmed | Vaccine hesitancy and coronavirus disease-19: Where do we stand? |
| title_short | Vaccine hesitancy and coronavirus disease-19: Where do we stand? |
| title_sort | vaccine hesitancy and coronavirus disease 19 where do we stand |
| topic | coronavirus disease-19 coronavirus disease-19 vaccine mistrust participants side effects vaccine acceptance vaccine hesitancy |
| url | http://www.jehp.net/article.asp?issn=2277-9531;year=2022;volume=11;issue=1;spage=59;epage=59;aulast=Khan |
| work_keys_str_mv | AT zaidkhan vaccinehesitancyandcoronavirusdisease19wheredowestand AT syedquibtiyakhursheed vaccinehesitancyandcoronavirusdisease19wheredowestand AT shabirahmaddar vaccinehesitancyandcoronavirusdisease19wheredowestand AT naveednazirshah vaccinehesitancyandcoronavirusdisease19wheredowestand AT shujareagu vaccinehesitancyandcoronavirusdisease19wheredowestand AT majidalabdulla vaccinehesitancyandcoronavirusdisease19wheredowestand AT inaamulhaq vaccinehesitancyandcoronavirusdisease19wheredowestand AT aaliyamohiuddinazad vaccinehesitancyandcoronavirusdisease19wheredowestand AT khurshidahmaddar vaccinehesitancyandcoronavirusdisease19wheredowestand AT syedsuraiyafarooq vaccinehesitancyandcoronavirusdisease19wheredowestand AT zaidahmadwani vaccinehesitancyandcoronavirusdisease19wheredowestand |